Imbed Biosciences is a privately held medical device company focused on wound care with its SAM™ Antimicrobial Technology, a fully synthetic, biocompatible wound matrix designed to protect wounds and support healing. The company markets products like Surgaflex, Pelashield, Microlyte, and PainGuard variants that integrate antimicrobial silver and, in some versions, lidocaine for pain relief. It operates primarily in the United States, with FDA registration and ISO 13485:2016 certification, and emphasizes a portfolio spanning acute, chronic, burn, surgical, and traumatic wounds.